Abstract:IntroductionMRI has been increasingly used in radiation therapy to facilitate tumor and organ delineation and assess treatment response. Diffusion MRI can provide cellularity information and may enable functional‐based treatment planning and adaptation. However, strong distortion associated with the conventional diffusion‐weighted single‐shot echo‐planar imaging (DW‐ssEPI) sequence is problematic for accurate target delineation. The goal of this work is to propose a 3D diffusion sequence with minimal distortion for radiation therapy applications.MethodsA 3D diffusion‐prepared magnitude‐stabilized balanced steady‐state free precession sequence (DP‐MS‐bSSFP) was developed. A 2D navigator was acquired during the linear catalyzation stage of the bSSFP readout to estimate the phase, which was then used in a plane‐by‐plane low‐rank constrained reconstruction to correct the shot‐to‐shot k‐space inconsistency. A diffusion phantom was scanned to evaluate and compare the geometric reliability and apparent diffusion coefficient (ADC) accuracy with the conventional DW‐ssEPI. Eight landmarks were selected on each slice of the images to calculate the target registration error (TRE), which was used as a surrogate for geometric fidelity. The phantom was scanned under both 0℃ and room temperature. Brain scans were performed on five healthy volunteers. In the first volunteer, protocols of 1, 2, and 4 shots per Kz plane were compared. In vivo geometric fidelity and ADC accuracy were evaluated on the remaining four volunteers using the protocol of four shots per Kz plane. In the geometric fidelity study, 8–10 landmarks were picked on each slice to calculate the TRE. Regions of interest were placed on the white matter, the cerebellum, and the cerebrospinal fluid region to evaluate the ADC agreement between DW‐ssEPI and DP‐MS using the Bland‐Altman plot. All scans were performed at 1.5 mm isotropic resolution to meet the high‐resolution requirement of many radiotherapy applications.ResultsThe DP‐MS had drastically improved geometric accuracy compared with DW‐ssEPI on the phantom. The mean TRE decreased from 2.09 mm to 0.70 mm. The percentage difference of the ADC values between the two diffusion sequences were less than 5.5% and 7% for the 0℃ and room temperature study, respectively. The DW‐ssEPI had strong distortion and susceptibility‐related artifacts at tissue air boundary, whereas distortion was minimal in DP‐MS images. Overall, the mean/max TRE was over 2 mm/7 mm in the volunteers for DW‐ssEPI, whereas less than 0.8 mm/2 mm for DP‐MS. Good ADC agreement was observed for the white matter, the cerebellum, and the CSF based on the Bland‐Altman plots.ConclusionA 3D diffusion sequence was developed and validated. It provided high‐resolution diffusion imaging with mean distortion less than 1 mm at 1.5 T, and is a promising imaging technique for treatment planning and adaptive radiotherapy.

Three‐dimensional EPI with shot‐selective CAIPIRIHANA for rapid high‐resolution quantitative susceptibility mapping at 3 T

3D-CAIPI-BUDA and Joint Hankel Low-Rank Reconstruction Enable Rapid and Distortion-free High-Resolution T2* Mapping and QSM

Three-dimensional Simultaneous Brain Mapping of T1, T2, T2*and Magnetic Susceptibility with MR Multitasking

3D Isotropic Resolution Diffusion-Prepared Magnitude-Stabilized Bssfp Imaging with High Geometric Fidelity at 1.5 Tesla

Clinical Quantitative Susceptibility Mapping (QSM): Biometal Imaging and Its Emerging Roles in Patient Care

Multiband accelerated 2D EPI for multi‐echo brain QSM at 3 T

Cerebral Microbleeds: Burden Assessment by Using Quantitative Susceptibility Mapping

Three-dimensional simultaneous brain T 1 , T 2 , and ADC mapping with MR Multitasking.

Feasibility of submillimeter functional quantitative susceptibility mapping using 3D echo planar imaging at 7 T

Spherical echo‐planar time‐resolved imaging (sEPTI) for rapid 3D quantitative T2* and susceptibility imaging

Simultaneous QSM and Metabolic Imaging of the Brain Using SPICE.

Clinical Feasibility of Brain Quantitative Susceptibility Mapping.

Multi-echo quantitative susceptibility mapping: how to combine echoes for accuracy and precision at 3 Tesla

(1)H spectroscopic imaging of human brain at 3 Tesla: comparison of fast three-dimensional magnetic resonance spectroscopic imaging techniques

Phase-sensitive deep reconstruction method for rapid multiparametric MR fingerprinting and quantitative susceptibility mapping in the brain

Multi-Echo Quantitative Susceptibility Mapping for Strategically Acquired Gradient Echo (STAGE) Imaging

Recommended Implementation of Quantitative Susceptibility Mapping for Clinical Research in The Brain: A Consensus of the ISMRM Electro-Magnetic Tissue Properties Study Group

Pushing functional MRI spatial and temporal resolution further: High‐density receive arrays combined with shot‐selective 2D CAIPIRINHA for 3D echo‐planar imaging at 7 T

An Interleaved Sequence for Simultaneous Magnetic Resonance Angiography (MRA), Susceptibility Weighted Imaging (SWI) and Quantitative Susceptibility Mapping (QSM).

Time-efficient, high-resolution 3T whole-brain relaxometry using 3D-QALAS with wave-CAIPI readouts

Accelerated Simultaneous T2 and T2* Mapping of Multiple Sclerosis Lesions Using Compressed Sensing Reconstruction of Radial RARE-EPI MRI